Retail & Wholesale » Retail | Xtant Medical Holdings Inc.

Xtant Medical Holdings Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
33,073.40
35,331.80
59,345.70
90,002.70
82,612.10
72,203
Cost of Goods Sold (COGS) incl. D&A
14,563.20
13,306.10
24,082.30
32,651.00
37,996.40
32,835
Gross Income
18,510.20
22,025.80
35,263.40
57,351.80
44,615.70
39,368
SG&A Expense
26,794.20
27,242.90
44,517.00
63,495.70
58,283.10
46,762
EBIT
8,284.10
5,352.20
-
6,143.90
13,667.40
7,394
Unusual Expense
146.40
823.50
2,554.50
684.60
23,964.40
52,563
Non Operating Income/Expense
97.80
318.80
170.00
351.90
74.70
3
Interest Expense
4,653.20
5,660.40
7,733.70
12,262.80
14,704.80
10,145
Pretax Income
12,693.10
10,507.90
19,711.80
19,443.20
52,411.30
70,099
Income Tax
-
-
17,537.40
50.40
-
-
Consolidated Net Income
12,693.10
10,507.90
2,174.40
19,493.60
52,411.30
70,099
Net Income
12,693.10
10,507.90
2,174.40
19,493.60
52,411.30
70,099
Net Income After Extraordinaries
12,693.10
10,507.90
2,174.40
19,493.60
52,411.30
70,099
Net Income Available to Common
12,693.10
10,507.90
2,174.40
19,493.60
52,411.30
70,099
EPS (Basic)
32.40
21.12
2.88
18.48
34.76
5.97
Basic Shares Outstanding
396.10
496.20
754.60
1,056.00
1,507.80
11,740.60
EPS (Diluted)
32.05
21.18
2.88
18.46
34.76
5.97
Diluted Shares Outstanding
396.10
496.20
754.60
1,056.00
1,507.80
11,740.60
EBITDA
7,530.60
4,399.90
4,364.40
1,098.00
5,273.60
1,655
Other Operating Expense
-
135.10
-
-
-
-

About Xtant Medical Holdings

View Profile
Address
664 Cruiser Lane
Belgrade Montana 59714
United States
Employees -
Website http://www.xtantmedical.com
Updated 07/08/2019
Xtant Medical Holdings, Inc. operates as a holding company, which supplies orthopedic and spine surgery products. The firm operates through its subsidiaries, Bacterin International, Inc. and X-spine Systems, Inc. Bacterin International develops, manufactures, and markets biologics products to domestic and international markets. Its products are bone graft, which are used in promotion of skull healing following neurosurgery and subchondral bone repair in knee and other joint surgeries; and custom surgical products used for allografts.